Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ailsa Hart

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
United European Gastroenterology Journal|October 13, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST StudyAxel Dignass, Fernando Magro, Ferdinando D'Amico, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.
Gastroenterology|March 20, 2025
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI StudyAilsa Hart, Remo Panaccione, Flavio Steinwurz, et al.
Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.
Trials|August 4, 2021
Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trialChristine Norton, Jonathan Syred, Sally Kerry, et al.
BMC Gastroenterology|August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and overStuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Annals of Gastroenterology|March 5, 2020
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experienceHajir Ibraheim, Mark A Samaan, Ashish Srinivasan, et al.
Gastrointestinal Endoscopy|April 17, 2018
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitisMark A Samaan, Bo Shen, Mahmoud H Mosli, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2022
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trialsJeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, et al.
The Lancet. Digital Health|November 8, 2025
Digital cognitive behavioural self-management programme for fatigue, pain, and faecal incontinence in inflammatory bowel disease (IBD-BOOST): a multicentre, parallel, randomised controlled trialRona Moss-Morris, Christine Norton, Ailsa Hart, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
United European Gastroenterology Journal|October 13, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST StudyAxel Dignass, Fernando Magro, Ferdinando D'Amico, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.
Gastroenterology|March 20, 2025
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI StudyAilsa Hart, Remo Panaccione, Flavio Steinwurz, et al.
Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.
Trials|August 4, 2021
Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trialChristine Norton, Jonathan Syred, Sally Kerry, et al.
BMC Gastroenterology|August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and overStuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Annals of Gastroenterology|March 5, 2020
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experienceHajir Ibraheim, Mark A Samaan, Ashish Srinivasan, et al.
Gastrointestinal Endoscopy|April 17, 2018
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitisMark A Samaan, Bo Shen, Mahmoud H Mosli, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2022
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trialsJeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, et al.
The Lancet. Digital Health|November 8, 2025
Digital cognitive behavioural self-management programme for fatigue, pain, and faecal incontinence in inflammatory bowel disease (IBD-BOOST): a multicentre, parallel, randomised controlled trialRona Moss-Morris, Christine Norton, Ailsa Hart, et al.
Pageof 18